ArticleEuropean journal of medical research2025
The use of a novel complication reporting system: the comprehensive complication index in thulium laser enucleation of the prostate.
Article in European journal of medical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Article
- Construction and application of a quality evaluation indicator system for intravenous therapy nursing.BMC nursing · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesTo evaluate the application of the comprehensive complication index (CCI) in the assessment of postoperative complications after thulium laser prostate enucleation (ThuLEP) and compare it with the Clavien‒Dindo classification (CDC) grading system.
methodsA retrospective analysis of the clinical data of 467 patients hospitalized for benign prostatic hyperplasia treated with ThuLEP surgery from August 2019 to October 2023 was conducted. The postoperative complications of patients were assessed via both the CDC and CCI complication evaluation systems, and the correlation between both systems and the postoperative length of stay (LOS) was analyzed. Sample size estimations for randomized controlled trials (RCTs) were also performed on the basis of complication rates and CCI scores.
resultsNinety-nine (21.20%) of the patients had a total of 121 complications. Eighteen patients experienced ≥ 2 types of complications, and their cumulative CCI scores exceeded the score corresponding to the highest CDC grade. Both the CDC and CCI were significantly and positively correlated with the postoperative LOS, with the cumulative CCI score showing a stronger correlation than the highest CDC grade (r = 0.429, p < 0.001 vs. r = 0.383, p < 0.001). Furthermore, the use of the CCI for evaluating postoperative complications was found to reduce the required sample size for RCTs (305 per group vs. 90 per group).
conclusionsCompared with the CDC, the CCI more accurately reflects short-term postoperative complications after ThuLEP and shows a stronger correlation with LOS while enabling smaller sample sizes in RCTs. Future studies should integrate the CCI into standardized reporting for laser-based BPH surgery to improve consistency and benchmarking.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.